A Trial to Test for Bioequivalence Between Two NN5401 Formulations in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2015
At a glance
- Drugs Insulin degludec/insulin aspart (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 17 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 May 2010 New trial record